Therapy-Related Myelodysplastic Syndrome Recruiting Phase 2 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

IndicationStatusPhase
DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs